What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Internal medicine
Her primary areas of study are Myeloid leukemia, Leukemia, Cancer research, Internal medicine and Oncology.
Her Myeloid leukemia research integrates issues from Karyotype, Bioinformatics, Immunophenotyping, Cytogenetics and Bone marrow.
Her Leukemia research includes elements of Myeloid, Gene, Chromosomal translocation and Neuroblastoma RAS viral oncogene homolog.
Her Cancer research research is multidisciplinary, incorporating elements of Mutation, Fms-Like Tyrosine Kinase 3, Gene expression profiling, Molecular biology and NPM1.
Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Pathology.
Her Oncology study combines topics from a wide range of disciplines, such as Proportional hazards model, Immunology and Transplantation.
Her most cited work include:
- Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. (870 citations)
- Dominant-negative mutations of CEBPA , encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia (775 citations)
- BRAF mutations in hairy-cell leukemia (749 citations)
What are the main themes of her work throughout her whole career to date?
Susanne Schnittger mainly investigates Leukemia, Internal medicine, Myeloid leukemia, Oncology and Immunology.
Her work deals with themes such as Myeloid, Molecular biology, NPM1 and Cytogenetics, which intersect with Leukemia.
Her research investigates the connection between Cytogenetics and topics such as Fluorescence in situ hybridization that intersect with issues in Chronic lymphocytic leukemia.
Her Internal medicine research incorporates elements of Gastroenterology, Karyotype and Pathology.
Her Myeloid leukemia study results in a more complete grasp of Cancer research.
Her Oncology study incorporates themes from Transplantation, Bioinformatics, Proportional hazards model, Imatinib and Cohort.
She most often published in these fields:
- Leukemia (48.67%)
- Internal medicine (44.99%)
- Myeloid leukemia (37.91%)
What were the highlights of her more recent work (between 2014-2020)?
- Internal medicine (44.99%)
- Leukemia (48.67%)
- Oncology (29.79%)
In recent papers she was focusing on the following fields of study:
Susanne Schnittger mainly investigates Internal medicine, Leukemia, Oncology, Immunology and Myeloid leukemia.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Karyotype.
The Leukemia study combines topics in areas such as Myeloid, KRAS, NPM1, Cytogenetics and ETV6.
The concepts of her Oncology study are interwoven with issues in Trisomy, Gene mutation, Neuroblastoma RAS viral oncogene homolog, Chromosome abnormality and Acute leukemia.
She combines subjects such as Young adult, Survival rate and Somatic evolution in cancer with her study of Immunology.
She interconnects Gene duplication, Fms-Like Tyrosine Kinase 3 and Philadelphia chromosome in the investigation of issues within Myeloid leukemia.
Between 2014 and 2020, her most popular works were:
- Genetic variation at MECOM , TERT , JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms (105 citations)
- Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V + advanced systemic mastocytosis (95 citations)
- Molecular diagnostics of myeloproliferative neoplasms (56 citations)
In her most recent research, the most cited papers focused on:
Susanne Schnittger mostly deals with Internal medicine, Mutation, Myeloid leukemia, Genetics and Myeloid.
Her Internal medicine study combines topics in areas such as Oncology and RUNX1.
Her research in Mutation intersects with topics in Molecular biology and NPM1.
Her Myeloid leukemia study improves the overall literature in Immunology.
Her research integrates issues of Essential thrombocythemia, Polycythemia vera and Disease in her study of Genetics.
Myeloid is a subfield of Cancer research that she tackles.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
